Women’s Health, Vaginal Microbiome, Recurrent BV, Thrush, UTIs

Why BV, Thrush and UTIs Keep Coming Back: The Vaginal Dysbiosis Connection and What extensive Testing Actually Reveals

Nearly every woman I see with recurrent BV, thrush or UTIs has the same underlying issue — vaginal dysbiosis with critically low Lactobacillus. In this article I’ll walk you through what that actually means, why standard treatment keeps failing, and how comprehensive vaginal microbiome testing can finally give us answers.

Introduction: The Pattern I See Every Day

I’m Kylie Sayce, a Nurse Practitioner working in women’s intimate health here in Australia. Almost every clinic day, I sit with women who are exhausted, embarrassed and frankly fed up with the same story: another round of bacterial vaginosis (BV), another bout of thrush, another urinary tract infection (UTI). Many have a plastic bag of past prescriptions on their phone or in their handbag — metronidazole, fluconazole, nitrofurantoin, trimethoprim — the list goes on. The pattern is strikingly similar across ages and life stages.

The story usually goes like this: symptoms flare, they see a GP or after-hours doctor, have a quick swab or urine test, receive antibiotics or antifungals, and things settle down for a while. Then, a few weeks or months later, it all comes back — sometimes worse, sometimes slightly different, but always disruptive. Sex becomes stressful. Holidays are overshadowed by packing “just in case” scripts. Some women start to feel as though their body is betraying them, or that it’s “all in their head” because tests keep coming back as “normal”.

When we look deeper, a very consistent underlying pattern appears. In women with recurrent BV, thrush and UTIs, comprehensive vaginal microbiome testing almost always shows the same thing: vaginal dysbiosis with critically low — often undetectable — levels of protective Lactobacillus bacteria. In other words, the ecosystem that should be protecting you is either severely depleted or completely missing. The infections are the smoke; the dysbiosis is the fire.

Standard treatment focuses on the infection of the day. It targets what is overgrowing — Gardnerella, Candida, E. coli — but not why those organisms were able to take over in the first place. Antibiotics and antifungals can be absolutely necessary, and I use them regularly. But used alone, without addressing the vaginal environment, they are like mopping up water from a leaking pipe without ever fixing the pipe. The puddle will keep returning, no matter how many times you clean it up.

Importantly, each woman’s microbiome and health history are unique. There is no one-size-fits-all protocol, no single probiotic that “fixes” everyone. My role is not to offer a magic cure, but to investigate carefully, explain clearly, and design an individualised, evidence-based plan that makes sense for your body. That process starts with understanding vaginal dysbiosis itself.

What Is Vaginal Dysbiosis and Why Does It Matter?

Vaginal dysbiosis simply means that the normal microbial community in the vagina has been disrupted. In a healthy state, the vagina is dominated by friendly bacteria called Lactobacillus. These bacteria, particularly species like Lactobacillus crispatus, create a low pH environment (around 3.5–4.5) by producing lactic acid, and many strains also produce hydrogen peroxide and other antimicrobial compounds. Think of Lactobacilli as the security guards of the vaginal ecosystem — they occupy space, use up resources, and make the environment hostile to would-be troublemakers.

When Lactobacilli are depleted — by antibiotics, hormonal shifts, new sexual partners, stress, or sometimes for reasons we still do not fully understand — the pH rises. Once pH creeps up above 4.5, that acid mantle is lost and the door opens for other organisms to move in. Anaerobic bacteria associated with BV, yeasts like Candida, and aerobic bacteria such as E. coli can then proliferate. This shift is what we call dysbiosis: a move away from a Lactobacillus-dominant, low-diversity community towards a more mixed, sometimes chaotic ecosystem dominated by opportunistic organisms.

In research, we often describe vaginal microbiomes in terms of Community State Types (CSTs). CST I, II and V are generally Lactobacillus-dominant (for example, CST I is usually L. crispatus-dominated) and associated with lower risk of BV and some sexually transmitted infections (STIs). CST IV, by contrast, is a dysbiotic pattern with low Lactobacillus and higher diversity of anaerobes such as Gardnerella vaginalis, Atopobium vaginae and various Prevotella species. A 2026 ecological model in PLOS Biology described this in terms of shared versus private nutrient use: healthy Lactobacillus communities thrive on shared resources like glycogen, whereas dysbiotic communities exploit “private” resources such as sialoglycans, reinforcing their dominance over time.

It is important to understand that dysbiosis is not just “a bit out of balance”. It is a clinically meaningful state associated with higher rates of recurrent BV, recurrent thrush, recurrent UTIs, pelvic inflammatory disease, and increased susceptibility to STIs, including chlamydia and HIV in some populations. A 2026 mini-review in Frontiers in Microbiology highlighted how dysbiosis promotes chronic inflammation and biofilm formation — sticky, protective layers that bacteria build on vaginal surfaces. These biofilms make infections harder to clear and more likely to recur, even after seemingly appropriate antibiotic courses.

For UTIs in particular, emerging research shows that the vaginal and rectal microbiomes can act as reservoirs for uropathogens. A 2026 study in postmenopausal women with recurrent UTIs found depletion of L. crispatus and L. iners, and enrichment of Gram-negative organisms and antimicrobial resistance markers in the vagina, often mirrored in the bowel. In other words, the problem is not just your bladder; it is the entire urogenital ecosystem. Without addressing that ecosystem, we are asking for the same infections to keep returning.

Recurrent symptoms usually reflect an underlying ecosystem imbalance, not just bad luck.

Why Antibiotics and Antifungals Alone Aren’t the Answer

In Australian general practice, antibiotics and antifungals are the mainstay for treating BV, thrush and UTIs. They are important tools, and used appropriately they can be life-saving. However, they are designed to treat an active infection, not to restore a healthy microbiome. This distinction matters enormously when we are dealing with recurrent problems rather than a one-off episode.

Take BV as an example. Metronidazole or clindamycin will generally reduce anaerobic BV-associated bacteria. You may feel better within days. But these medications do not rebuild Lactobacillus levels. In fact, broad-spectrum antibiotics can further deplete any remaining Lactobacilli, especially if taken repeatedly or combined with other courses for unrelated infections such as sinusitis or chest infections. This can leave the vaginal environment even more vulnerable once the antibiotic is stopped, particularly if biofilms remain on the vaginal walls protecting residual BV bacteria from full eradication.

Similarly, antifungals such as fluconazole or clotrimazole reduce the burden of Candida, but they do not address why Candida was able to overgrow in the first place. In many of the women I see with recurrent thrush, comprehensive microbiome testing shows that Lactobacillus levels are already critically low. Once that protective barrier is gone, Candida can quickly reclaim space after the antifungal course ends, especially if underlying drivers such as high oestrogen states, poorly controlled diabetes or frequent antibiotic exposure are still present. If the species is something like Candida glabrata or Candida krusei, which can be less sensitive or resistant to standard azoles, the problem is compounded further.

For UTIs, short antibiotic courses are often essential to relieve acute symptoms and prevent complications. But if the vagina and perineal area remain colonised with high levels of E. coli or other uropathogens, and Lactobacillus remains depleted, the same bacteria are waiting at the doorstep of the urethra. A change in sexual activity, a long car trip without toilet breaks, or even a mild viral illness that alters immune function can be enough to tip things back into another infection. Again, the underlying ecological problem has not been resolved — only the latest flare-up has been suppressed.

📌 Key Point: The answer is not to stop treating infections. It is to combine appropriate treatment with active microbiome restoration, so that we change the environment that keeps allowing these infections to develop.

Why Just Taking Probiotics Isn’t the Answer Either

By the time many women reach my clinic, they have already tried several over-the-counter probiotics. Some have spent hundreds of dollars on capsules, powders, yoghurts and vaginal pessaries marketed for “feminine balance”. Understandably, they feel frustrated when these products don’t seem to make any lasting difference. This is not because probiotics are useless. It is because timing, strain selection and context are crucial, and these are rarely discussed on the label.

Imagine trying to grow a lush lawn on a slab of concrete. You can buy the best grass seed in the world, but if you scatter it over hard, dry cement, it will not take root. In the same way, if your vaginal microbiome is dominated by high levels of Candida, BV-associated bacteria or aerobic pathogens like E. coli, simply adding Lactobacillus probiotics is often like throwing seed onto concrete. The conditions are not yet right for those friendly bacteria to colonise and persist. They may pass through temporarily, but the dominant organisms quickly reclaim their territory once the probiotic course ends.

I have sees microbiome results where, for example, Candida albicans is measured at 576.87 ×105 CFU/ml (more than 576 times the reference range), or E. coli is significantly elevated, while total Lactobacilli sit at 0.01 ×106 CFU/ml — effectively absent. In that context, probiotics alone are unlikely to succeed. First, we need to reduce the competing organisms and disrupt biofilms. Only then does it make sense to actively reseed with targeted Lactobacillus strains, and to support them with the right pH and hormonal environment so they can actually stay.

Probiotics can help, but only when chosen carefully and used at the right time.

The order of treatment matters. In my clinic, vaginal microbiome restoration typically follows a RESET then REBUILD approach. We first RESET by treating active infections and reducing pathogen load. Only after that do we REBUILD the Lactobacillus community with evidence-based strains. Research into live biotherapeutic products, such as L. crispatus CTV-05 (LACTIN-V), shows that colonisation success depends heavily on the baseline microbiota and the vaginal environment. Women whose vaginas are already dominated by dysbiotic communities are less likely to maintain long-term colonisation from a single probiotic strain, especially if other factors like sexual practices, smoking, or hormonal status are not addressed alongside.

The specific strains used also matter. Not all probiotics are equal, and not all strains are suited to vaginal colonisation. Many products marketed for “women’s health” actually contain gut-focused species that may have limited impact on the vagina. For vaginal microbiome restoration, we look for strains with evidence of vaginal persistence and lactic acid production, such as particular strains of L. crispatus, L. rhamnosus, L. gasseri and others. Even then, each woman’s microbiome is different, so we use test results to guide which strains are most appropriate and how they should be delivered (oral, vaginal or both).

💡 Pro Tip: If you have tried multiple probiotics without improvement, it does not mean your body “can’t” restore a healthy microbiome. It usually means we need to change the strategy, not give up on the concept altogether.

What Standard Testing Misses

In most Australian settings, if you present with discharge, odour, itching or burning, you will have a standard vaginal swab or urine test. These tests are designed to answer a very specific question: “What infection do you have today?” They usually look for BV (using Amsel criteria or a Nugent score), Candida, sometimes trichomonas, and a limited panel of STIs. They are useful, but they are not designed to tell us about the overall health of your vaginal ecosystem. As a result, significant dysbiosis can be completely missed, or dismissed as “within normal limits”.

I often see women whose BV tests are repeatedly reported as “negative”, yet their symptoms and pH readings clearly suggest a disrupted environment. One memorable example was a woman with a vaginal pH of 5.8 (well above the protective 3.5–4.5 range), Candida albicans measured at 576.87 ×105 CFU/ml (extremely elevated), and total Lactobacilli at just 0.01 ×106 CFU/ml — essentially absent. Despite this, her standard BV swab was reported as NEGATIVE, and she was told her tests were “normal” except with some "thrush". From a microbiome perspective, nothing about this picture was normal. She had profound dysbiosis and almost no protective foundation to prevent future infections.

This is not a rare exception. It is a common story among women with recurrent symptoms who attend my clinic for vaginal microbiome testing in Australia. Standard testing simply is not built to answer the more important question: “Why does your body keep allowing these infections to come back?” To answer that, we need a more comprehensive, quantitative look at the entire ecosystem — not just a yes/no result for one or two organisms.

What Vaginal Microbiome Mapping Actually Measures

Vaginal microbiome mapping is a more detailed, quantitative assessment of the organisms living in your vagina. In Australia, this is usually done via a self-collected or clinician-collected vaginal swab sent to a specialised laboratory using quantitative PCR and related methods. The exact panels vary between providers, but a comprehensive test will typically include the following components.

pH Measurement

Vaginal pH is a simple but powerful indicator of microbiome health. In a healthy, Lactobacillus-dominant vagina, pH is typically between 3.5 and 4.5. Lactobacilli maintain this acidity by producing lactic acid from glycogen released under the influence of oestrogen. When pH rises above 4.5, it suggests loss of Lactobacillus dominance and increased susceptibility to BV, aerobic vaginitis and other infections. In the example patient I mentioned earlier, a pH of 5.8 was a clear sign that the protective acid mantle was compromised.

Bacterial Vaginosis Panel (Quantitative PCR)

A BV panel looks at specific organisms strongly associated with BV and biofilm formation, often reported in colony-forming units per millilitre (CFU/ml) or similar quantitative metrics. Key organisms include:

• Gardnerella vaginalis — the most commonly recognised BV organism, known for forming resilient biofilms on vaginal epithelial cells.

• Atopobium vaginae (Fannyhessea vaginae) — strongly associated with recurrent BV and biofilm persistence; often difficult to eradicate fully with standard antibiotics alone.

• Megasphaera species — anaerobes linked with BV and higher vaginal pH.

• Prevotella species — produce enzymes such as proteases and sialidases that can damage vaginal mucosa and mucus, further destabilising the environment.

• BVAB2 — a highly specific marker for BV in many studies.

• Mobiluncus species and Bacteroides fragilis — anaerobes often seen in BV-associated dysbiosis.

Aerobic Vaginitis Panel (Quantitative PCR)

Aerobic vaginitis involves inflammation driven by aerobic (oxygen-loving) bacteria rather than the classic anaerobes of BV. A comprehensive panel may include:

• Escherichia coli — the most common cause of UTIs and a frequent vaginal coloniser in dysbiosis. In our example case, it was measured at 22.94 ×105 CFU/ml (reference <1.00), indicating a very high burden.

• Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae (Group B Strep), Streptococcus dysgalactiae and Staphylococcus epidermidis — organisms that can contribute to inflammation, discharge and recurrent infections, and are particularly important in pregnancy and pelvic health.

Bacterial Vaginal Pathogens

Broader panels also look for other potential pathogens such as:

• Haemophilus influenzae, Klebsiella pneumoniae, Leptothrix species, Peptostreptococcus species, Proteus mirabilis, Pseudomonas aeruginosa, Streptococcus pyogenes and Streptococcus pneumoniae.

Mollicutes and Sexually Transmitted Infections

Mollicutes such as Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum are increasingly recognised contributors to urogenital symptoms and pelvic inflammatory disease. Comprehensive STI panels typically include Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex viruses 1 and 2, Haemophilus ducreyi, lymphogranuloma venereum, Treponema pallidum (syphilis), cytomegalovirus and varicella-zoster virus. Identifying these accurately is crucial for appropriate treatment and partner management.

Mycology: Candida Species (Quantitative PCR)

Rather than just reporting “yeast present”, microbiome mapping often specifies the species and quantity of Candida, such as:

• Candida albicans — the most common species, but not the only one; in our example: 576.87 ×105 CFU/ml (reference <1.00).

• Candida dubliniensis, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis — each with different typical antifungal sensitivities.

Speciation matters because, for instance, Candida glabrata and Candida krusei can be less responsive or resistant to standard fluconazole. If you are repeatedly treated with fluconazole for an infection caused by a species that does not respond well to it, it is unsurprising that symptoms keep returning. Knowing the exact species allows us to choose more appropriate antifungal strategies and to plan restoration with realistic expectations.

Beneficial Bacteria: Lactobacillus Panel (Quantitative)

For me, this is often the most clinically important part of the report. A robust Lactobacillus community is the foundation of vaginal health. A typical panel reports:

• Total Lactobacilli (reference >1.00 ×106 CFU/ml). In our example: 0.01 ×106 CFU/ml — critically low.

• Lactobacillus crispatus — widely considered the “gold standard” protective species, associated with low pH and reduced BV and STI risk. In our example: 0.01, virtually absent.

• Lactobacillus gasseri, L. iners, L. jensenii, L. rhamnosus, L. salivarius, L. vaginalis — each contributing in different ways to acid production, mucosal adherence and pathogen exclusion. In many of my recurrent cases, these are all at or below detection limits.

Detailed microbiome mapping helps explain why infections recur despite standard treatment.

When all Lactobacillus species are at or near zero, there is essentially no protective bacterial foundation. In that scenario, no amount of repeated antibiotics or antifungals will create a stable, healthy microbiome on their own. This is exactly what we find in the majority of women who present to our clinic with long-standing, recurrent BV, thrush and UTIs — which is why our focus is on structured, individualised vaginal microbiome restoration rather than just “stronger” or “longer” courses of the same medications.

The Vaginal Microbiome Restoration Program: A 5-Step Individualised Approach

Because every woman’s test results, history and goals are different, we do not use a single generic protocol. In my clinic, no care plan is written until we have seen the microbiome results and discussed your broader health context. However, most individual plans follow the same overarching framework — a five-step vaginal microbiome restoration program. Think of it as a roadmap rather than a rigid recipe, always adapted to your situation and in line with current evidence and Australian clinical guidelines.

An effective restoration plan is structured, stepwise and tailored to your microbiome results.

Step 1 — RESET: Treat the Active Infection

The first priority is to reduce the immediate burden of pathogens and relieve symptoms. This often involves targeted antibiotics or antifungals, chosen based on the specific organisms and, where possible, their known or likely sensitivities. For BV, that might mean metronidazole or clindamycin, sometimes in combination with strategies aimed at disrupting biofilms (for example, certain vaginal preparations that help break down the protective matrix). For thrush, it may involve oral or topical azoles, or alternative agents if non-albicans species are identified. For UTIs, treatment is guided by urine culture and local resistance patterns, with careful attention to the impact on the vaginal microbiome.

During this phase, we also look at modifiable factors that may be fuelling dysbiosis: unnecessary antibiotic use, douching or scented washes, poorly controlled blood glucose, smoking, and unprotected intercourse with new partners. The goal is not blame, but understanding. Each of these elements can be part of the “leak in the pipe” that keeps refilling the puddle. Addressing them early improves the chances that later restoration steps will hold.

Step 2 — REBUILD: Restore Protective Lactobacillus

Once pathogen load is reduced and symptoms are settling, we move into the rebuilding phase. Here, the aim is to re-establish a Lactobacillus-dominant microbiome, ideally with strong representation from L. crispatus or other protective species. We use targeted probiotic strategies, often combining oral and vaginal routes, and select strains based on the evidence for vaginal colonisation and on what is missing in your own microbiome profile.

Timing is critical. Introducing probiotics too early — while BV bacteria or Candida are still dominating — can limit their ability to adhere and persist. Introducing them too late, without maintenance, can allow dysbiosis to creep back in. We usually plan the REBUILD phase to follow closely after RESET, sometimes overlapping slightly, and we monitor symptoms and, where appropriate, repeat testing to assess progress. Current research on live biotherapeutic products, including the 2026 LACTIN-V trial, suggests that sustained colonisation is more likely when the environment has already shifted towards health, reinforcing the importance of this sequencing.

Step 3 — RESTORE: Create a Healthy Vaginal Environment

Even the best probiotics will struggle if the surrounding environment is not supportive. In the RESTORE phase, we focus on optimising vaginal pH, supporting healthy mucus production, and addressing hormonal influences. Oestrogen plays a key role in maintaining vaginal tissue integrity and glycogen levels, which in turn feed Lactobacilli. In perimenopausal and postmenopausal women, or in those using certain hormonal contraceptives, we may discuss whether local oestrogen therapy or other hormonal strategies are clinically appropriate, always within current guidelines and in collaboration with your broader care team where needed.

Lifestyle and self-care factors also matter: choosing breathable cotton underwear, avoiding perfumed products, managing blood sugar, supporting sleep and stress management, and ensuring adequate lubrication during sex (with products that are pH- and microbiome-friendly). These may sound simple, but taken together they help create a “fertile soil” in which Lactobacilli can thrive, rather than constantly battling against irritation and microtrauma.

Step 4 — MAINTAIN: Keep the Microbiome Healthy

Once we have achieved a more stable, Lactobacillus-rich microbiome and symptom relief, we shift into a maintenance phase. This is where many women in standard care are left without guidance — they finish their treatment and are told to “come back if it returns”. In contrast, we plan maintenance on purpose. This may involve a less frequent probiotic schedule, ongoing attention to pH-friendly products, regular check-ins, and sometimes repeat microbiome testing at agreed intervals to ensure the ecosystem remains stable, especially if there are known risk factors such as diabetes, frequent travel, or upcoming surgeries that may involve antibiotics.

The length of maintenance varies; for some women it may be a few months, for others it may be longer. The goal is not to keep you on endless supplements, but to support your body while the new balance consolidates. Over time, the hope — and often the reality — is that your vaginal microbiome becomes more self-sustaining, needing only occasional support during higher-risk periods.

Step 5 — RESCUE: Act Early When Triggers Occur

Finally, we plan for the reality that life happens. Illnesses, stress, new relationships, travel, antibiotics for other conditions — all of these can temporarily destabilise the vaginal microbiome. Rather than waiting for a full-blown relapse, we develop a personalised rescue plan. This might include a short, pre-agreed course of vaginal probiotics after any systemic antibiotic use, earlier review if certain symptoms or triggers appear, or specific steps to take around high-risk times such as perioperative periods or long-haul flights. Acting early can often prevent a minor wobble from turning into another long cycle of BV, thrush or UTIs.

Our Philosophy: Asking the Right Question

In my practice, we do not simply ask, “What infection do you have today?” We ask, “Why does your body keep allowing these infections to come back?” That shift in question changes everything. It moves us from chasing each flare-up to understanding and addressing the underlying ecosystem that is driving the pattern. By identifying vaginal dysbiosis, quantifying Lactobacillus depletion, and mapping out which organisms are actually present, we can design care that is informed, individualised and realistic about both benefits and limitations.

This approach is not a quick fix, and it is not a guarantee. Vaginal microbiome restoration takes time, and each woman’s journey is different. Some notice improvements quickly; others require a longer, more stepwise process. My role is to provide clear information, evidence-based options and ongoing support, so that you can make decisions that feel right for you.

Understanding the underlying microbiome can help you move from crisis management to long-term support.

If You’re Going in Circles with BV, Thrush or UTIs

If you are an Australian woman experiencing recurrent BV, thrush or UTIs and feel as though you are going in circles, it may be time to look beyond standard swabs and short courses of medication. Vaginal microbiome testing in Australia can help reveal whether vaginal dysbiosis and critically low Lactobacillus are part of the picture for you, and whether a structured vaginal microbiome restoration program might be appropriate as part of your care. This is not about promising cures; it is about providing a more complete assessment and a thoughtful, evidence-informed plan.

If you would like to explore this further, you can book an appointment with me, Kylie Sayce NP, to discuss your history, symptoms and whether comprehensive testing is suitable in your situation. Consultations are educational and collaborative, with a focus on helping you understand your options and make informed decisions. You can book online at: https://www.halaxy.com/book/appointment/kylie-sayce-np/location/1353833.

Whether you choose to see me or another clinician, my encouragement is this: if your BV, thrush or UTIs keep coming back, it is reasonable to ask why. You deserve care that looks beyond the infection of the day and considers the health of your whole vaginal ecosystem.